New Clinical Trial is Testing a Ketamine Skin Cream for PTSD
PRESS ROOM
PSYCHECEUTICAL IN THE PRESS

NeuroDirect™ Ketamine: Novel, Non-Systemic Topical Therapy for PTSD & Associated Intractable Depression

Top Biotech Startup 2023 – Psycheceutical: Leveraging the Therapeutic Power of Psychedelics

Novel Psychedelic Treatment Approach Bypasses Hallucinogenic Effects to Allow Widespread Adoption

Psychedelic Business Spotlight: Psycheceutical, Inc., Announces Exclusive License of Two Major Patents